Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Depreciation & Amortization (CF) (2016 - 2018)

Armata Pharmaceuticals' Depreciation & Amortization (CF) history spans 6 years, with the latest figure at $261000.0 for Q4 2018.

  • For Q4 2018, Depreciation & Amortization (CF) rose 196.59% year-over-year to $261000.0; the TTM value through Dec 2018 reached $1.4 million, up 308.16%, while the annual FY2024 figure was $1.3 million, 36.32% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2018 was $261000.0 at Armata Pharmaceuticals, down from $337000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $713000.0 in Q2 2018 and bottomed at -$27000.0 in Q3 2014.
  • The 5-year median for Depreciation & Amortization (CF) is $85000.0 (2016), against an average of $133294.1.
  • The largest annual shift saw Depreciation & Amortization (CF) tumbled 228.57% in 2014 before it soared 738.82% in 2018.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $68000.0 in 2014, then fell by 14.71% to $58000.0 in 2015, then soared by 60.34% to $93000.0 in 2016, then dropped by 5.38% to $88000.0 in 2017, then skyrocketed by 196.59% to $261000.0 in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Depreciation & Amortization (CF) are $261000.0 (Q4 2018), $337000.0 (Q3 2018), and $713000.0 (Q2 2018).